Testing effectiveness (Phase 2)Study completedNCT02503345
What this trial is testing
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
Who this might be right for
Secondary HyperoxaluriaNephrolithiasisKidney Stones+2 more
Allena Pharmaceuticals 32